TY - JOUR
T1 - Neuropathologic basis of white matter hyperintensity accumulation with advanced age
AU - Erten-Lyons, Deniz
AU - Woltjer, Randall
AU - Kaye, Jeffrey
AU - Mattek, Nora
AU - Dodge, Hiroko
AU - Green, Sarah
AU - Tran, Huong
AU - Howieson, Diane
AU - Wild, Katherine
AU - Silbert, Lisa C.
PY - 2013/9/10
Y1 - 2013/9/10
N2 - Objective: To determine which vascular pathology measure most strongly correlates with white matter hyperintensity (WMH) accumulation over time, and whether Alzheimer disease (AD) neuropathology correlates with WMH accumulation. Methods: Sixty-six older persons longitudinally followed as part of an aging study were included for having an autopsy and >1 MRI scan, with last MRI scan within 36 months of death. Mixed-effects models were used to examine the associations between longitudinal WMH accumulation and the following neuropathologic measures: myelin pallor, arteriolosclerosis, microvascular disease, microinfarcts, lacunar infarcts, large-vessel infarcts, atherosclerosis, neurofibrillary tangle rating, and neuritic plaque score. Each measure was included one at a time in the model, adjusted for duration of follow-up and age at death. A final model included measures showing an association with p < 0.1. Results: Mean age at death was 94.5 years (5.5 SD). In the finalmixed-effects models, arteriolosclerosis, myelin pallor, and Braak score remained significantly associated with increasedWMH accumulation over time. In post hoc analysis, we found that those with Braak score 5 or 6 were more likely to also have high atherosclerosis present compared with those with Braak score 1 or 2 (p = 0.003). Conclusion: Accumulating white matter changes in advanced age are likely driven by small-vessel ischemic disease. Additionally, these results suggest a link between AD pathology and white matter integrity disruption. This may be due to wallerian degeneration secondary to neurodegenerative changes. Alternatively, a shared mechanism, for example ischemia, may lead to both vascular brain injury and neurodegenerative changes of AD. The observed correlation between atherosclerosis and AD pathology supports the latter.
AB - Objective: To determine which vascular pathology measure most strongly correlates with white matter hyperintensity (WMH) accumulation over time, and whether Alzheimer disease (AD) neuropathology correlates with WMH accumulation. Methods: Sixty-six older persons longitudinally followed as part of an aging study were included for having an autopsy and >1 MRI scan, with last MRI scan within 36 months of death. Mixed-effects models were used to examine the associations between longitudinal WMH accumulation and the following neuropathologic measures: myelin pallor, arteriolosclerosis, microvascular disease, microinfarcts, lacunar infarcts, large-vessel infarcts, atherosclerosis, neurofibrillary tangle rating, and neuritic plaque score. Each measure was included one at a time in the model, adjusted for duration of follow-up and age at death. A final model included measures showing an association with p < 0.1. Results: Mean age at death was 94.5 years (5.5 SD). In the finalmixed-effects models, arteriolosclerosis, myelin pallor, and Braak score remained significantly associated with increasedWMH accumulation over time. In post hoc analysis, we found that those with Braak score 5 or 6 were more likely to also have high atherosclerosis present compared with those with Braak score 1 or 2 (p = 0.003). Conclusion: Accumulating white matter changes in advanced age are likely driven by small-vessel ischemic disease. Additionally, these results suggest a link between AD pathology and white matter integrity disruption. This may be due to wallerian degeneration secondary to neurodegenerative changes. Alternatively, a shared mechanism, for example ischemia, may lead to both vascular brain injury and neurodegenerative changes of AD. The observed correlation between atherosclerosis and AD pathology supports the latter.
UR - http://www.scopus.com/inward/record.url?scp=84884574818&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884574818&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e3182a43e45
DO - 10.1212/WNL.0b013e3182a43e45
M3 - Article
C2 - 23935177
AN - SCOPUS:84884574818
SN - 0028-3878
VL - 81
SP - 977
EP - 983
JO - Neurology
JF - Neurology
IS - 11
ER -